Haemoglobinopathy Screening
Cross-source consensus on Haemoglobinopathy Screening from 1 sources and 6 claims.
1 sources · 6 claims
Uses
How it works
Preparation
Risks & contraindications
Evidence quality
Highlighted claims
- The study used the Gazelle Hb variant point-of-care device for haemoglobinopathy screening. — Haemoglobinopathies and health disparities: findings of a large-scale sample survey among indigenous populations in Odisha, India
- The Gazelle device separates haemoglobin types by charge using electrophoresis principles. — Haemoglobinopathies and health disparities: findings of a large-scale sample survey among indigenous populations in Odisha, India
- The device outputs were interpreted to identify conditions including sickle cell disease, sickle cell trait, beta-thalassaemia major, and beta-thalassaemia minor. — Haemoglobinopathies and health disparities: findings of a large-scale sample survey among indigenous populations in Odisha, India
- Screening programmes should be expanded in tribal regions for early detection and timely management. — Haemoglobinopathies and health disparities: findings of a large-scale sample survey among indigenous populations in Odisha, India
- The device had prior validation against reference methods including HPLC and haemoglobin electrophoresis. — Haemoglobinopathies and health disparities: findings of a large-scale sample survey among indigenous populations in Odisha, India
- Point-of-care testing without confirmatory laboratory methods may have allowed misclassification of haemoglobin variants. — Haemoglobinopathies and health disparities: findings of a large-scale sample survey among indigenous populations in Odisha, India